Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
Australia has the potential to become the first country in the world to eliminate cancer as a public health problem.
Read Full NewsIZAR-1: Sonelokimab Meets Phase 3 End Points for PsA
Two-season real-world data show Arexvy reduces RSV-related MACE and COPD and asthma exacerbations in adults 60 and older, Ann Falsey, MD, says.
Guy Brusselle, MD, PhD, says that 64% of dupilumab-treated patients met composite asthma clinical remission criteria at week 24 versus 40.5% with omalizumab.
What The FDA Psychedelic Hearing Means for Psychiatrists
A new phase 4 trial, OCTAGON, will test a rapid, predefined corticosteroid-tapering schedule in patients with generalized myasthenia gravis treated with ravulizumab.
A phase 4 study is evaluating whether adults with chronic inflammatory demyelinating polyneuropathy can transition from intravenous immunoglobulin to subcutaneous efgartigimod PH20 without first experiencing disease worsening.
Real-world 12‑month results from WeSMA, a phase 4 study, showed that oral risdiplam is well tolerated in adults with SMA, with stable motor function and consistent safety findings.
1.
Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven
2.
US Mental Health Treatment Rates Rise But Gaps Persist
3.
Next Day Mood Is Affected by Ability to Recover From Work.
4.
Geriatric Assessment, QoL Correlate With OS in Older Patients with Pancreatic Cancer
5.
Aster Whitefield Hospital, with 506 beds, opened.
1.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
2.
Living Better With Advanced Cancer Through Supportive Care
3.
Hematopoietic Aging and Functional Blood Health: Mechanisms, Clinical Implications, and Advances
4.
The Science Behind Thrombolytic Drugs and Their Benefits
5.
Quality of Life Through Identity Reconstruction and Social Reintegration After Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
2.
How Iron Deficiency Can Affect Energy and Concentration
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Navigating the Complexities of Ph Negative ALL - Part IV
5.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge